Acrivon Therapeutics, Inc. Common Stock (ACRV) is a publicly traded Healthcare sector company. As of October 20, 2026, ACRV trades at $1.78 with a market cap of $70.28M and a P/E ratio of -0.93. ACRV moved +5.03% today. Year to date, ACRV is -31.30%; over the trailing twelve months it is -6.63%. Its 52-week range spans $1.05 to $5.75. Analyst consensus is strong buy with an average price target of $10.50. Rallies surfaces ACRV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ACRV financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ACRV recently traded at $1.78. Market cap is $70.28M. P/E ratio is -0.93. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $1.78 |
| Market Cap | $70.28M |
| P/E Ratio | -0.93 |
| EPS | $-2.02 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.75 |
| 52-Week Low | $1.05 |
| Volume | 34.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-77.91M |
| Gross Margin | 0.00% |
4 analysts cover ACRV: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.50.